US 12,233,244 B2
Autoinjector
Carsten Mosebach, Frankfurt am Main (DE); and Thomas Kemp, Ashwell (GB)
Assigned to Sanofi-Aventis Deutschland GMBH, Frankfurt am Main (DE)
Filed by Sanofi-Aventis Deutschland GMBH, Frankfurt am Main (DE)
Filed on Apr. 24, 2023, as Appl. No. 18/305,766.
Application 18/305,766 is a continuation of application No. 16/859,143, filed on Apr. 27, 2020, granted, now 11,660,396.
Application 16/859,143 is a continuation of application No. 15/125,014, granted, now 10,646,654, issued on May 12, 2020, previously published as PCT/EP2015/056686, filed on Mar. 27, 2015.
Claims priority of application No. 14162454 (EP), filed on Mar. 28, 2014.
Prior Publication US 2024/0325643 A1, Oct. 3, 2024
Int. Cl. A61M 5/20 (2006.01); A61M 5/32 (2006.01)
CPC A61M 5/2033 (2013.01) [A61M 5/3204 (2013.01); A61M 2005/2013 (2013.01); A61M 2005/2073 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A drug delivery device comprising:
a housing arranged to receive a medicament container, the medicament container having a needle at a distal end of a body of the medicament container and a removable needle shield, the removable needle shield covering the needle,
a cap arranged at a distal end of the housing, the cap being removable from the housing,
a needle shroud telescopically coupled to the housing and movable between a first extended position relative to the housing in which the needle is covered and a retracted position relative to the housing in which the needle is exposed,
a first shroud lock mechanism arranged to prevent movement of the needle shroud relative to the housing into the retracted position when the cap is in place, wherein the first shroud lock mechanism comprises one or more compliant shroud beams on the cap and a respective number of apertures in the needle shroud adapted to receive each of the compliant shroud beams, and
a second shroud lock mechanism arranged to prevent movement of the needle shroud relative to the housing towards the retracted position when the needle shroud is in a second extended position after a drug delivery operation,
wherein the cap is coupled to the removable needle shield such that the removable needle shield is removed from the needle when the cap is removed from the housing.